J.P. Morgan Maintains CME Group(CME.US) With Sell Rating, Raises Target Price to $209
Morgan Stanley Maintains CME Group(CME.US) With Hold Rating, Raises Target Price to $233
Morgan Stanley Sticks to Its Hold Rating for CME Group (CME)
Morgan Stanley Raises Price Target on CME Group to $233 From $210, Keeps Equalweight Rating
CME Group Is Maintained at Outperform by Oppenheimer
CME Gr Analyst Ratings
Oppenheimer Maintains CME Group(CME.US) With Buy Rating, Raises Target Price to $245
Goldman Sachs Trims Price Target on CME to $197 From $198, Maintains Sell Rating
Jefferies Maintains CME Group(CME.US) With Buy Rating, Raises Target Price to $254
Piper Sandler Maintains CME Group(CME.US) With Buy Rating, Raises Target Price to $240
Piper Sandler Sticks to Its Buy Rating for CME Group (CME)
Redburn Atlantic Downgrades CME Group(CME.US) to Hold Rating, Raises Target Price to $244
CME Group Downgraded to Neutral From Buy at Redburn Atlantic
CME Gr Analyst Ratings
Barclays Adjusts CME Group's Price Target to $219 From $209, Keeps Equalweight Rating
CME Group (CME) Receives a Hold From Barclays
A Quick Look at Today's Ratings for CME Group(CME.US), With a Forecast Between $180 to $275
RBC Capital Maintains CME Group(CME.US) With Hold Rating, Maintains Target Price $235
Citi Maintains CME Group(CME.US) With Buy Rating, Raises Target Price to $250
BofA Securities Maintains CME Group(CME.US) With Sell Rating, Raises Target Price to $180